Orient Pharma Financials
| 4166 Stock | TWD 37.00 0.05 0.14% |
Orient |
Understanding current and past Orient Pharma Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Orient Pharma's financial statements are interrelated, with each one affecting the others. For example, an increase in Orient Pharma's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Orient Pharma's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Orient Pharma Co. Check Orient Pharma's Beneish M Score to see the likelihood of Orient Pharma's management manipulating its earnings.
Orient Pharma Stock Summary
Orient Pharma competes with Fu Burg, I Jang, Hunya Foods, Yi Jinn, and International CSRC. Orient Pharma Co., Ltd. researches, develops, manufactures, and sells drugs in Taiwan and internationally. Orient Pharma Co., Ltd. is a subsidiary of Orient Europharma Co., Ltd. ORIENT PHARMA operates under Drug Manufacturers - Major classification in Taiwan and is traded on Taiwan OTC Exchange.| Instrument | Taiwan Stock View All |
| Exchange | Taiwan OTC Exchange |
| Business Address | No 368, Fu |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Major |
| Benchmark | Dow Jones Industrial |
| Website | www.oppharma.com |
| Phone | 886 2 2325 7621 |
| Currency | TWD - New Taiwan Dollar |
You should never invest in Orient Pharma without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Orient Stock, because this is throwing your money away. Analyzing the key information contained in Orient Pharma's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Orient Pharma Key Financial Ratios
There are many critical financial ratios that Orient Pharma's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Orient Pharma reports annually and quarterly.| Return On Equity | -14.97 | |||
| Return On Asset | -8.89 | |||
| Number Of Employees | 13 | |||
| Beta | 0.62 | |||
| Z Score | 6.0 |
Orient Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Orient Pharma's current stock value. Our valuation model uses many indicators to compare Orient Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Orient Pharma competition to find correlations between indicators driving Orient Pharma's intrinsic value. More Info.Orient Pharma Co is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Orient Pharma's earnings, one of the primary drivers of an investment's value.Orient Pharma Systematic Risk
Orient Pharma's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Orient Pharma volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Orient Pharma correlated with the market. If Beta is less than 0 Orient Pharma generally moves in the opposite direction as compared to the market. If Orient Pharma Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Orient Pharma is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Orient Pharma is generally in the same direction as the market. If Beta > 1 Orient Pharma moves generally in the same direction as, but more than the movement of the benchmark.
Orient Pharma December 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Orient Pharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Orient Pharma Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of Orient Pharma Co based on widely used predictive technical indicators. In general, we focus on analyzing Orient Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Orient Pharma's daily price indicators and compare them against related drivers.
| Downside Deviation | 5.19 | |||
| Information Ratio | 0.1331 | |||
| Maximum Drawdown | 31.12 | |||
| Value At Risk | (5.03) | |||
| Potential Upside | 8.81 |
Additional Tools for Orient Stock Analysis
When running Orient Pharma's price analysis, check to measure Orient Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orient Pharma is operating at the current time. Most of Orient Pharma's value examination focuses on studying past and present price action to predict the probability of Orient Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orient Pharma's price. Additionally, you may evaluate how the addition of Orient Pharma to your portfolios can decrease your overall portfolio volatility.